Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05310071 |
|---|---|
| Brief Title: | A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease (ENVISION) |
| First Submitted : | March 25, 2022 |
| First Submitted that Met QC Criteria : | March 25, 2022 |
| First Posted : | April 4, 2022 |
| Last Update Submitted that Met QC Criteria : | February 9, 2024 |
| Last Update Posted : | February 12, 2024 |